Scientists have uncovered a key link between aging and chronic inflammation, which plays a major role in the decline of bodily functions as people grow older. The research, published in the journal Nature, shows that malfunctioning mitochondria—tiny structures inside cells responsible for producing energy—play a central role in this process. As cells age, some become "senescent," meaning they stop dividing but remain active, often referred to as "zombie" cells due to their harmful effects on surrounding tissues. These senescent cells use their mitochondria to activate inflammatory genes, keeping the immune system in a constant state of alert. This chronic inflammation is thought to contribute to many age-related conditions, such as arthritis, heart disease, and cognitive decline. The study, conducted by researchers from the Sanford Burnham Prebys Medical Discovery Institute, Mayo Clinic, and other institutions, identified two specific mitochondrial processes that work together to drive this inflammation. The first process involves an increase in the production of a molecule called acetyl-CoA, which helps in the packaging of DNA. This change in DNA structure makes inflammatory genes more accessible and easier to activate. The second process occurs when damaged mitochondria leak their genetic material—DNA and RNA—into the cell. The immune system interprets this leakage as a sign of cellular damage or infection, triggering a response that further amplifies inflammation. In an encouraging development, researchers tested a drug called CTPI-2 that targets the acetyl-CoA metabolic pathway. In mice, this drug reduced inflammation and improved tissue function, suggesting a potential new strategy for treating age-related decline. These findings open the door to therapies that could help reduce the harmful effects of aging by targeting mitochondrial dysfunction and chronic inflammation.